| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RIGEL PHARMACEUTICALS INC | Director | Common Stock | 9.38K | $179K | $19.06 | May 23, 2025 | Direct |
| Aclaris Therapeutics, Inc. | Chief Legal Officer | Common Stock | 160K | $168K | $1.05 | Jan 3, 2022 | Direct |
| PDS Biotechnology Corp | Director | Employee Stock Option (Right to Buy) | 22.7K | Jun 11, 2025 | Direct | ||
| PDS Biotechnology Corp | Director | Employee Stock Option (Right to Buy) | 9K | Jun 24, 2024 | Direct | ||
| RIGEL PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 3K | May 23, 2025 | Direct | ||
| Aclaris Therapeutics, Inc. | Chief Legal Officer | Restricted Stock Units | 0 | $1.05 | Jan 3, 2022 | Direct | |
| Aclaris Therapeutics, Inc. | Chief Legal Officer | Employee Stock Option (Right to Buy) | 0 | May 7, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PDSB | PDS Biotechnology Corp | Jun 11, 2025 | 1 | $0 | 4 | Jun 11, 2025 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 23, 2025 | 2 | $0 | 4 | May 28, 2025 | Director |
| PDSB | PDS Biotechnology Corp | Jun 24, 2024 | 1 | $0 | 4 | Jun 25, 2024 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 25, 2024 | 2 | $0 | 4 | May 29, 2024 | Director |
| PDSB | PDS Biotechnology Corp | Jul 14, 2023 | 1 | $0 | 4 | Jul 17, 2023 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 26, 2023 | 2 | $0 | 4 | Jul 12, 2023 | Director |
| PDSB | PDS Biotechnology Corp | Jun 28, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | May 20, 2022 | 2 | $0 | 4 | May 23, 2022 | Director |
| ACRS | Aclaris Therapeutics, Inc. | Jan 3, 2022 | 8 | $0 | 4 | Jan 5, 2022 | Chief Legal Officer |
| RIGL | RIGEL PHARMACEUTICALS INC | Dec 16, 2021 | 1 | $0 | 4 | Dec 17, 2021 | Director |
| RIGL | RIGEL PHARMACEUTICALS INC | Dec 16, 2021 | 0 | $0 | 3 | Dec 17, 2021 | Director |
| PDSB | PDS Biotechnology Corp | Jun 15, 2021 | 2 | $100K | 4 | Jun 17, 2021 | Director |
| ACRS | Aclaris Therapeutics, Inc. | Jun 3, 2021 | 1 | -$208K | 4 | Jun 4, 2021 | Chief Legal Officer |
| ACRS | Aclaris Therapeutics, Inc. | Jun 1, 2021 | 8 | -$997K | 4 | Jun 2, 2021 | Chief Legal Officer |
| ACRS | Aclaris Therapeutics, Inc. | May 6, 2021 | 8 | -$261K | 4 | May 7, 2021 | Chief Legal Officer |
| ACRS | Aclaris Therapeutics, Inc. | Mar 11, 2021 | 1 | $0 | 4 | Nov 22, 2021 | Chief Legal Officer |